RL
Rudy Li Wolfe Research Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
36
Avg Return
Past Year
Past Year
42%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
94.4%
Neutral
5.6%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Initiated
| $40 |
50%
upside
| 5 | +18% |
0
%
| 24 Feb ‘26 9 days ago |
|
|
|
Outperform
Initiated
| $45 |
54%
upside
| 1 | -9% |
0
%
| 24 Feb ‘26 9 days ago |
|
|
|
Outperform
Initiated
| $230 |
40%
upside
| 1 | -6.1% |
0
%
| 24 Feb ‘26 9 days ago |
|
|
|
Outperform
Initiated
| $60 |
39%
upside
| 5 | +4.4% |
0
%
| 24 Feb ‘26 9 days ago |
|
|
|
Outperform
Initiated
| $40 |
16%
upside
| 3 | +72% |
0
%
| 24 Feb ‘26 9 days ago |
|
|
|
Peer Perform
Initiated
| – | – | 1 | – |
–
| 24 Feb ‘26 9 days ago |
|
|
|
Peer Perform
Initiated
| – | – | 1 | – |
–
| 24 Feb ‘26 9 days ago |
|
|
|
Outperform
Initiated
| $500 |
54%
upside
| 4 | +89% |
0
%
| 24 Feb ‘26 9 days ago |
|
|
|
Outperform
Initiated
| $160 |
20%
upside
| 1 | +3.9% |
0
%
| 24 Feb ‘26 9 days ago |
|
|
|
Outperform
Initiated
| $25 |
41%
upside
| 3 | +44% |
0
%
| 24 Feb ‘26 9 days ago |
|
|
|
Outperform
Initiated
| $33 |
41%
upside
| 1 | -5.4% |
0
%
| 24 Feb ‘26 9 days ago |
|
|
|
Buy
Maintained
| $80 |
1%
upside
| 3 | +51% |
0
%
| 2 Jan ‘26 2 months ago |
|
|
|
Buy
Initiated
| $3 |
156%
upside
| 1 | +25% |
0
%
| 29 Sep ‘25 5 months ago |
|
|
|
Buy
Initiated
| $15 |
30%
downside
| 1 | +443% |
0
%
| 29 Sep ‘25 5 months ago |
|
|
|
Buy
Initiated
| $2 |
719%
upside
| 1 | -17% |
0
%
| 29 Sep ‘25 5 months ago |
|
|
|
Buy
Maintained
| $18 |
83%
upside
| 4 | +9.2% |
0
%
| 28 Aug ‘25 6 months ago |
|